Cullin1 regulates proliferation, migration and invasion of glioma cells

Medical Oncology

Volumn 31, Issue 10, 2014, Pages 1-8

  Fan, Yue Chao ^a   Zhu, Yi Shuo ^a   Mei, Peng Jin ^a   Sun, Sheng Guang ^a   Zhang, Hui ^a   Chen, Hong Fu ^a   Chen, Chen ^a   Miao, FA An ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cul1; Glioma; Invasion; Migration; Proliferation

Indexed keywords

CULLIN; CULLIN 1; CYCLIN A; CYCLIN D1; CYCLIN E; GELATINASE A; GELATINASE B; PROTEIN P21; PROTEIN P27; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN;

ARTICLE; BRAIN TISSUE; CANCER GROWTH; CANCER TISSUE; CARCINOGENESIS; CELL CYCLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; GLIOBLASTOMA CELL LINE; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RNA INTERFERENCE; TISSUE MICROARRAY; TUMOR INVASION; UPREGULATION; BRAIN NEOPLASMS; CELL MOTION; CLINICAL TRIAL; FEMALE; GENETICS; GLIOMA; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE; WESTERN BLOTTING;

BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL CYCLE PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CULLIN PROTEINS; FEMALE; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED;

EID: 84919951771     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0227-x     Document Type: Article

References (19)

1. Reardon DA, et al. Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy. J Neurooncol. 2011;103(2):371–9.
2. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell. 1994;79(1):13–21.
3. Reinstein E, Ciechanover A. Narrative review: protein degradation and human diseases: the ubiquitin connection. Ann Intern Med. 2006;145(9):676–84.
4. Nakayama KI, Nakayama K. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin Cell Dev Biol. 2005;16(3):323–33.
5. Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer. 2006;6(5):369–81.
6. Petroski MD, Deshaies RJ. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol. 2005;6(1):9–20.
7. Dealy MJ, et al. Loss of Cul1 results in early embryonic lethality and dysregulation of cyclin E. Nat Genet. 1999;23(2):245–8.
8. Van Rechem C, et al. The SKP1-Cul1-F-box and leucine-rich repeat protein 4 (SCF-FbxL4) ubiquitin ligase regulates lysine demethylase 4A (KDM4A)/Jumonji domain-containing 2A (JMJD2A) protein. J Biol Chem. 2011;286(35):30462–70.
9. Mei PJ, et al. RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration. J Cancer Res Clin Oncol. 2011;137(12):1823–30.
10. Bai J, et al. Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer. Hum Pathol. 2011;42(3):375–83.
11. Bai J, et al. Cullin1 is a novel marker of poor prognosis and a potential therapeutic target in human breast cancer. Ann Oncol. 2013;24(8):2016–22.
12. Xu M, et al. High expression of Cullin1 indicates poor prognosis for NSCLC patients. Pathol Res Pract. 2014;210(7):397–401.
13. Chen G, et al. Cul1 expression is increased in early stages of human melanoma. Pigment Cell Melanoma Res. 2010;23(4):572–4.
14. Zheng Q, et al. CDK-associated Cullin 1 can promote cell proliferation and inhibit cisplatin-induced apoptosis in the AGS gastric cancer cell line. World J Surg Oncol. 2013;11:5.
15. Konigsberg R, et al. Cell cycle dysregulation influences survival in high risk breast cancer patients. Cancer Invest. 2008;26(7):734–40.
16. Eigeliene N, Harkonen P, Erkkola R. Effects of estradiol and medroxyprogesterone acetate on expression of the cell cycle proteins cyclin D1, p21 and p27 in cultured human breast tissues. Cell Cycle. 2008;7(1):71–80.
17. Barcellos-Hoff MH, et al. Therapeutic targets in malignant glioblastoma microenvironment. Semin Radiat Oncol. 2009;19(3):163–70.
18. Gritsenko PG, Ilina O, Friedl P. Interstitial guidance of cancer invasion. J Pathol. 2012;226(2):185–99.
19. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006;25(1):9–34.